13F

Investor

22NW, LP

CIK 0001694297 · filed 2026-05-15 · SEC filing

13F book

$145.9M

Positions

16

1 new · 5 sold

Largest name

20.4%

Foster L B Co · FSTR

Est. mark

−$3.96M

Price effect on 15 names still held. Flow −$87.7M.
NameTickerSharesValueWeightEst. markChange
Foster L B CoFSTR1.07M$29.8M20.4%$1.01MCut−$2.32M
Nektar TherapeuticsNKTR281.1K$20.2M13.9%$8.34MCut$6.23M
Lifecore Biomedical Inc1.25K$18.9M12.9%−$4.16MHeld
Insperity, Inc.NSP493K$13.3M9.1%−$1.12MAdded$9.6M
Mineralys Therapeutics, Inc.MLYS444.3K$12M8.2%−$3.3MAdded−$966.9K
Stoneridge IncSRI2.47M$11.9M8.2%−$2.11MAdded−$780.6K
Fox Factory Hldg Corp678.2K$11.2M7.6%New
Culp IncCULP1.86M$5.09M3.5%−$1.52MHeld
Core Molding Technologies In222.7K$4.99M3.4%$523.4KHeld
REGENXBIO Inc.RGNX492.8K$4.13M2.8%−$2.97MCut−$9.17M
Unifi IncUFI852.5K$3.04M2.1%$59.7KHeld
Team IncTISI170.2K$2.71M1.9%$308KHeld
Rezolute, Inc.RZLT820.7K$2.5M1.7%$566.3KHeld
Farmer Bros Co1.96M$2.48M1.7%−$371.6KHeld
Eledon Pharmaceuticals, Inc.ELDN636.4K$1.96M1.3%$999.1KHeld
Phenixfin Corp43.1K$1.68M1.2%−$220.7KCut−$3.52M

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.